1. 370 Pharmacodynamic assessment of a novel FAP-targeted 4–1BB agonist, administered as single agent and in combination with atezolizumab to patients with advanced solid tumors. (10th December 2020) Authors: Moreno, Victor; Hernandez, Tatiana; Melero, Ignacio; Sanmamed, Miguel; Spanggaard, Iben; Rohrberg, Kristoffer Staal; Tabernero, Josep; Azaro, Analia; Garcia, Maria Martinez; Rodriguez-Vida, Alejo; Claus, Christina; Heil, Florian; Krieter, Oliver; Grimm, Oliver; Canamero, Marta; Duarte, Jose; Nica... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 370 Pharmacodynamic assessment of a novel FAP-targeted 4–1BB agonist, administered as single agent and in combination with atezolizumab to patients with advanced solid tumors. (9th November 2020) Authors: Moreno, Victor; Hernandez, Tatiana; Melero, Ignacio; Sanmamed, Miguel; Spanggaard, Iben; Rohrberg, Kristoffer Staal; Tabernero, Josep; Azaro, Analia; Garcia, Maria Martinez; Rodriguez-Vida, Alejo; Claus, Christina; Heil, Florian; Krieter, Oliver; Grimm, Oliver; Canamero, Marta; Duarte, Jose; Nica... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Avelumab for the treatment of urothelial cancer. Issue 5 (4th May 2018) Authors: Rodriguez-Vida, Alejo; Bellmunt, Joaquim Journal: Expert review of anticancer therapy Issue: Volume 18:Issue 5(2018) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Complexity of FGFR signalling in metastatic urothelial cancer. Issue 1 (December 2015) Authors: Rodriguez-Vida, Alejo; Saggese, Matilde; Hughes, Simon; Rudman, Sarah; Chowdhury, Simon; Smith, Neil; Lawrence, Peter; Rooney, Claire; Dougherty, Brian; Landers, Donal; Kilgour, Elaine; Arkenau, Hendrik-Tobias Journal: Journal of hematology & oncology Issue: Volume 8:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cytoreductive nephrectomy: past, present and future. Issue 3 (March 2014) Authors: Galazi, Myria; Rodriguez-Vida, Alejo; Josephides, Eleni; Chau, Noan-Minh; Chowdhury, Simon Journal: Expert review of anticancer therapy Issue: Volume 14:Issue 3(2014) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial. Issue 7 (July 2021) Authors: Powles, Thomas; Csőszi, Tibor; Özgüroğlu, Mustafa; Matsubara, Nobuaki; Géczi, Lajos; Cheng, Susanna Y-S; Fradet, Yves; Oudard, Stephane; Vulsteke, Christof; Morales Barrera, Rafael; Fléchon, Aude; Gunduz, Seyda; Loriot, Yohann; Rodriguez-Vida, Alejo; Mamtani, Ronac; Yu, Evan Y; Nam, Kijoeng; Imai... Journal: Lancet oncology Issue: Volume 22:Issue 7(2021) Page Start: 931 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Precision medicine for prostate cancer. Issue 11 (November 2014) Authors: Galazi, Myria; Rodriguez-Vida, Alejo; Ng, Tony; Mason, Malcolm; Chowdhury, Simon Journal: Expert review of anticancer therapy Issue: Volume 14:Issue 11(2014) Page Start: 1305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial. Issue 10109 (18th November 2017) Authors: Petrylak, Daniel P; de Wit, Ronald; Chi, Kim N; Drakaki, Alexandra; Sternberg, Cora N; Nishiyama, Hiroyuki; Castellano, Daniel; Hussain, Syed; Fléchon, Aude; Bamias, Aristotelis; Yu, Evan Y; van der Heijden, Michiel S; Matsubara, Nobuaki; Alekseev, Boris; Necchi, Andrea; Géczi, Lajos; Ou, Yen-Chu... Journal: Lancet Issue: Volume 390:Issue 10109(2017) Page Start: 2266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial. Issue 1 (January 2020) Authors: Petrylak, Daniel P; de Wit, Ronald; Chi, Kim N; Drakaki, Alexandra; Sternberg, Cora N; Nishiyama, Hiroyuki; Castellano, Daniel; Hussain, Syed A; Fléchon, Aude; Bamias, Aristotelis; Yu, Evan Y; van der Heijden, Michiel S; Matsubara, Nobuaki; Alekseev, Boris; Necchi, Andrea; Géczi, Lajos; Ou, Yen-C... Journal: Lancet oncology Issue: Volume 21:Issue 1(2020) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The role of metastasectomy in renal cell carcinoma. Issue 12 (December 2013) Authors: Josephides, Eleni; Rodriguez-Vida, Alejo; Galazi, Myria; Chowdhury, Simon; Suder, Aneta Journal: Expert review of anticancer therapy Issue: Volume 13:Issue 12(2013) Page Start: 1363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗